Atlas Trials

Low-dose Selumetinib for the Treatment of Plexiform Neurofibromas in Chinese Children

Clinical trial NCT06763315 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06763315
Sponsor
West China Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Plexiform Neurofibromas (PN)
Start date
2025-01-01
Primary completion
2028-01-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.